Related Experiment Video
Updated: Jan 19, 2026

Mass Cytometry: Protocol for Daily Tuning and Running Cell Samples on a CyTOF Mass Cytometer
Published on: November 2, 2012
High-Parameter Immune Profiling with CyTOF
Bita Sahaf1, Adeeb Rahman2, Holden T Maecker3
1PICI Cancer Correlative Science Unit, Cancer Institute, Stanford University School of Medicine, Stanford, CA, USA.
Insights
Mass cytometry (CyTOF) enables high-parameter single-cell analysis of immune cells, crucial for tracking cancer immunotherapy responses. This study provides a reference panel and best practices to minimize batch variability for robust immune monitoring.
Area of Science:
- Immunology
- Biotechnology
- Computational Biology
Background:
- Mass cytometry (CyTOF) is a powerful tool for high-parameter single-cell analysis.
- Monitoring systemic immune changes is vital for cancer immunotherapy research.
- Standardized protocols are needed for reliable immune cell phenotyping.
Purpose of the Study:
- To present a comprehensive reference panel for identifying major immune cell populations using mass cytometry.
- To describe best practices for minimizing and tracking batch variability in CyTOF experiments.
- To demonstrate automated analysis of CyTOF data using the Astrolabe platform.
Main Methods:
- Development of a flexible reference panel for immune cell identification.
- Implementation of sample barcoding, spiked-in reference cells, and lyophilized antibody cocktails to control batch effects.
- Utilizing cryopreserved peripheral blood mononuclear cells (PBMCs) for sample batching and comparability.
- Application of the Astrolabe platform for automated data analysis.
Main Results:
- A validated reference panel capable of identifying diverse immune cell populations was established.
- The described methods effectively minimized and tracked batch variability in CyTOF data.
- Cryopreserved PBMCs facilitated consistent sample processing and analysis.
- Automated analysis using Astrolabe provided efficient and reproducible results.
Conclusions:
- This protocol provides a robust framework for high-parameter immune cell phenotyping using mass cytometry.
- The presented methods enhance the reliability and comparability of CyTOF data in cancer immunotherapy studies.
- Automated analysis offers a streamlined approach for processing complex CyTOF datasets.
Abstract:
Mass cytometry, or CyTOF, is a useful technology for high-parameter single-cell phenotyping, especially from suspension cells such as blood or PBMC. It is particularly appealing to monitor the systemic immune changes that could accompany cancer immunotherapy. Here we present a reference panel for identification of all major immune cell populations, with flexibility for addition of trial-specific markers. We also describe best-practice measures for minimizing and tracking batch variability. These include: sample barcoding, use of spiked-in reference cells, and lyophilization of the antibody cocktail. Our protocol assumes the use of cryopreserved PBMC, both for convenience of batching samples and for maximum comparability across patients and time points. Finally, we show an option for automated analysis using the Astrolabe platform (Astrolabe Diagnostics, Inc.).
More Related Videos
Related Concept Videos
10:59Mass Cytometry: Protocol for Daily Tuning and Running Cell Samples on a CyTOF Mass Cytometer
08:25Mass Cytometry Analysis of Systemic and Local Immune Responses in Hepatocellular Carcinoma
What is the Immune System?
Wave Parameters
Humoral Immune Responses
08:32Enrichment and Characterization of the Tumor Immune and Non-immune Microenvironments in Established Subcutaneous Murine Tumors

